New Wearable Devices
6 updatesOura Ring 5 Adds Continuous Blood Pressure Estimation
Oura's fifth-generation ring now includes photoplethysmography-based blood pressure estimation, updated hourly. Early validation data shows ±5 mmHg accuracy against ambulatory monitors in 82% of users. This eliminates the need for a separate cuff for trend tracking — though Oura stresses it's not a diagnostic device. Existing Gen 4 users get the algorithm via firmware update.
Source: Oura HealthWhoop MG Launches With Clinical-Grade ECG and AFib Detection
Whoop's new Medical Grade (MG) band received FDA 510(k) clearance for atrial fibrillation detection during rest. The device uses a 6-lead ECG configuration via wrist and bicep contact points. At $399/year subscription, it's positioned between consumer wearables and medical devices. Data integrates directly with Epic and Cerner EHR systems for physician review.
Source: Whoop Inc.Apple Watch Ultra 3 Introduces Non-Invasive Hydration Tracking
Apple's Ultra 3 uses bioimpedance spectroscopy through the watch's back sensors to estimate sweat sodium concentration and total body water status. Accuracy tested against deuterium dilution gold standard in a Stanford study of 340 athletes. The feature targets endurance athletes and aging adults where chronic dehydration accelerates cognitive decline. Available on Ultra models only due to sensor requirements.
Source: AppleLevels Health Releases Standalone Biosensor Patch — No CGM Required
Levels launched a 14-day adhesive biosensor patch that tracks heart rate variability, skin temperature, galvanic skin response, and estimated cortisol patterns — without requiring a continuous glucose monitor. At $89 per patch cycle, it's designed for users who want metabolic stress data without the CGM commitment. Early user data shows strong correlation with salivary cortisol tests (r=0.74).
Source: Levels HealthGarmin Fenix 9 Adds Biological Age Estimation Algorithm
Garmin's flagship multisport watch now estimates biological age using a proprietary algorithm combining VO2 max trends, HRV baseline, resting heart rate trajectory, sleep architecture quality, and activity consistency over 90+ days. Garmin partnered with the Buck Institute for validation. The feature requires a Garmin Connect+ subscription ($7.99/month). Independent validation studies are pending.
Source: GarminEight Sleep Pod 5 Tracks Respiratory Rate and Snoring Events via Radar
The Pod 5 mattress cover replaces piezoelectric sensors with millimeter-wave radar, achieving clinical-grade respiratory rate accuracy (±0.5 breaths/min) and detecting snoring events with 94% sensitivity. The upgrade enables sleep apnea risk screening without wearables. Eight Sleep filed for FDA De Novo classification for the apnea screening feature — decision expected Q1 2027.
Source: Eight SleepResearch & Data Updates
5 updatesJAMA Study: HRV Trends Predict All-Cause Mortality 8 Years Out
A longitudinal study of 14,200 adults published in JAMA Internal Medicine found that declining HRV over a 2-year period predicted all-cause mortality with a hazard ratio of 2.3 — independent of traditional risk factors. The study used consumer wearable data (Oura, Apple Watch) validated against research-grade ECG. This is the largest study to date linking consumer HRV trends to hard mortality endpoints.
Source: JAMA Internal MedicineNature Aging: Wearable Sleep Data Outperforms Self-Report for Cognitive Decline Prediction
Researchers at UCSF analyzed 3.2 million nights of wearable sleep data from 8,400 adults aged 55–80. Objective sleep efficiency and REM percentage declines predicted mild cognitive impairment 3 years before clinical diagnosis with 78% sensitivity — significantly outperforming self-reported sleep quality questionnaires (51% sensitivity). The study argues for mandatory wearable sleep data in cognitive screening protocols.
Source: Nature AgingStanford Validates Continuous Glucose Variability as Aging Biomarker
A Stanford-Longo lab collaboration demonstrated that glucose coefficient of variation (CV) measured over 14 days via CGM correlates with epigenetic age acceleration (r=0.41) in non-diabetic adults. Participants with glucose CV below 15% showed biological ages 3.2 years younger on average than those above 20% CV — independent of mean glucose. This positions glucose stability, not just glucose level, as a trackable aging signal.
Source: Cell MetabolismChest Strap HRV Still 3x More Accurate Than Wrist Wearables During Exercise
A systematic review of 47 studies in Sports Medicine confirmed that chest-strap ECG monitors (Polar H10, Garmin HRM-Pro) maintain ±1% HRV accuracy during exercise, while wrist-based PPG devices (Apple Watch, Whoop, Oura) degrade to ±8–12% accuracy above 120 BPM. For resting HRV, wrist devices are now statistically equivalent to chest straps. The takeaway: use wrist for recovery tracking, chest strap for training load analysis.
Source: Sports MedicineUK Biobank: Step Count Consistency Matters More Than Daily Total
An analysis of 78,000 UK Biobank participants with wearable data found that day-to-day step count consistency (low coefficient of variation) predicted lower cardiovascular event rates more strongly than average daily step count. People walking 7,000 steps ±500 daily had 18% fewer cardiac events than those averaging 9,000 steps ±4,000. Regularity of movement appears to be an underappreciated longevity signal.
Source: The Lancet Public HealthGet the 2027 Roundup First
Join 12,400+ readers tracking the wearable longevity space. One email when the next annual edition drops. No spam, no weekly blasts.
Platform & Software Changes
5 updatesApple Health Opens Longevity Score API to Third-Party Apps
Apple's iOS 20 update includes a HealthKit Longevity Score API that aggregates sleep, activity, HRV, and glucose data into a single 0–100 longevity readiness score. Third-party apps can now pull this score and build on it. Apple partnered with the American Federation for Aging Research (AFAR) for scoring methodology. The score updates daily and includes a 90-day trendline.
Source: Apple DeveloperWhoop Discontinues Free Tier — All Users Now Subscription-Only
Whoop eliminated its limited free access tier in September, requiring a $30/month or $239/year subscription for all functionality. The company cited the cost of clinical-grade sensor R&D and FDA clearance processes. Existing free users received a 60-day grace period. The move signals that FDA-cleared wearable features will increasingly require premium subscriptions to sustain.
Source: WhoopOura Integrates With InsideTracker for Personalized Biomarker Action Plans
Oura's partnership with InsideTracker now auto-generates intervention recommendations based on blood biomarker results mapped against wearable trend data. If your hsCRP is elevated and your HRV is declining, the system flags inflammation-driven recovery issues and suggests evidence-tiered interventions. The integration requires both an Oura subscription and InsideTracker membership ($249+).
Source: Oura HealthGarmin Connect+ Adds Longevity Dashboard With Multi-Device Data Fusion
Garmin's premium Connect+ tier now includes a Longevity Dashboard that fuses data from Garmin watches, Index scales, HRM straps, and third-party CGM integrations into a unified aging-rate visualization. The dashboard estimates pace-of-aging using a model trained on the UK Biobank cohort. Monthly aging-rate reports replace the previous "Fitness Age" metric with a more comprehensive biological age estimate.
Source: GarminGoogle Fitbit Platform Migrates All Data to Google Health — Users Report Gaps
Google completed the Fitbit-to-Google Health migration in January, consolidating all historical data. However, thousands of users reported missing HRV records, corrupted sleep stage data, and broken third-party API connections during the transition. Google acknowledged "data integrity issues affecting approximately 3% of migrated accounts" and offered data recovery tools. Trust in Fitbit's data continuity took a significant hit among longevity-focused users.
Source: 9to5GoogleRegulations & Standards
4 updatesFDA Finalizes "Wellness Wearable" Category — No Prescription Required for HRV, Sleep, Recovery Metrics
The FDA's final guidance on "General Wellness Wearables" explicitly exempts HRV tracking, sleep staging, recovery scoring, and stress estimation from medical device classification — provided no diagnostic claims are made. This clears the regulatory path for consumer devices to display these metrics without 510(k) clearance. Devices making disease-specific claims (AFib detection, sleep apnea screening) still require clearance.
Source: FDA.govEU MDR Classifies All Biometric Wearables as Class IIa Medical Devices Starting 2027
The European Union's Medical Device Regulation update reclassifies wearables measuring HRV, SpO2, ECG, and skin temperature as Class IIa medical devices effective January 2027. Manufacturers must obtain CE marking through notified body review. Several smaller wearable companies (Ultrahuman, Amazfit) have paused EU sales while pursuing certification. Apple, Garmin, and Oura are expected to comply by the deadline.
Source: European CommissionCalifornia AB 2847 Requires Wearable Companies to Disclose Data Accuracy Ranges
California's new consumer protection law requires any wearable sold in the state to publish accuracy ranges for health metrics (HRV ±X%, SpO2 ±X%, etc.) on packaging and product pages. Companies must cite validation studies or state "not clinically validated." Enforcement begins March 2027. The law is expected to set a de facto national standard given California's market size.
Source: California LegislatureHIPAA Expansion Proposed to Cover Consumer Wearable Health Data
A bipartisan Senate bill proposes extending HIPAA protections to health data collected by consumer wearables — including HRV, sleep, activity, and glucose data shared with third-party apps. If passed, wearable companies would need Business Associate Agreements with data-sharing partners and breach notification obligations. The bill has committee approval but faces industry lobbying from both tech and insurance sectors.
Source: U.S. SenateTrends & Shifts
4 updates"Pace of Aging" Replaces Biological Age as the Metric Everyone's Tracking
The longevity community shifted from snapshot biological age scores (TruAge, GrimAge) to pace-of-aging metrics that measure rate of change over time. Wearable-derived pace-of-aging scores using HRV, sleep, and activity trajectories are now considered more actionable than single-point epigenetic tests. The trend was driven by Duke University's DunedinPACE algorithm becoming available through consumer platforms.
Source: VitalPulse AnalysisMulti-Wearable Stacking Becomes the Norm — Average User Now Wears 2.3 Devices
A Consumer Technology Association survey found that longevity-focused wearable users now average 2.3 devices simultaneously — typically a wrist device plus a ring or patch. The most common stack: Apple Watch or Garmin (daytime activity + ECG) + Oura Ring (sleep + nighttime HRV). The trend drives demand for unified data platforms and is creating a new category of "data aggregator" apps.
Source: CTAWearable Companies Pivot From Tracking to Prescriptive Coaching
Every major wearable platform launched or expanded AI coaching features in 2026 — moving from passive data display to active intervention recommendations. Oura's "What to Do Today," Whoop's "Optimal Strain Targets," and Apple's "Readiness Actions" all use machine learning on personal trend data to suggest specific sleep, activity, and recovery adjustments. The shift reflects user demand for guidance, not just dashboards.
Source: VitalPulse AnalysisInsurance Companies Begin Offering Premium Discounts for Wearable Data Sharing
UnitedHealthcare and Aetna launched pilot programs offering 8–15% premium reductions for members who share wearable health data (HRV trends, activity consistency, sleep scores) through opt-in programs. The data is used to identify low-risk profiles, not to deny coverage. Early results show participating members have 22% fewer claims. Privacy advocates have raised concerns despite the opt-in structure.
Source: Health Affairs